Cargando…
MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
BACKGROUND: This study aimed at assessing the long-term effects of intranasal insulin (INI) on cognition and gait in older people with and without type 2 diabetes mellitus (T2DM). METHODS: Phase 2 randomized, double-blinded trial consisted of 24 week treatment with 40 IU of INI (Novolin(®) R, off-la...
Autores principales: | Novak, Vera, Mantzoros, Christos S., Novak, Peter, McGlinchey, Regina, Dai, Weiying, Lioutas, Vasileios, Buss, Stephanie, Fortier, Catherine B., Khan, Faizan, Aponte Becerra, Laura, Ngo, Long H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046533/ https://www.ncbi.nlm.nih.gov/pubmed/35482079 http://dx.doi.org/10.1007/s00415-022-11119-6 |
Ejemplares similares
-
Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial
por: Aponte Becerra, L, et al.
Publicado: (2022) -
Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
por: Buss, Stephanie S., et al.
Publicado: (2022) -
Intranasal insulin neuroprotection in ischemic stroke
por: Lioutas, Vasileios-Arsenios, et al.
Publicado: (2016) -
A structural MRI study of differential neuromorphometric characteristics of binge and heavy drinking
por: Maksimovskiy, Arkadiy L., et al.
Publicado: (2019) -
Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
por: Novak, Peter, et al.
Publicado: (2019)